Christopher P. Locher

1.4k total citations
33 papers, 995 citations indexed

About

Christopher P. Locher is a scholar working on Virology, Epidemiology and Molecular Biology. According to data from OpenAlex, Christopher P. Locher has authored 33 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Virology, 19 papers in Epidemiology and 13 papers in Molecular Biology. Recurrent topics in Christopher P. Locher's work include HIV Research and Treatment (19 papers), Herpesvirus Infections and Treatments (9 papers) and Tuberculosis Research and Epidemiology (6 papers). Christopher P. Locher is often cited by papers focused on HIV Research and Treatment (19 papers), Herpesvirus Infections and Treatments (9 papers) and Tuberculosis Research and Epidemiology (6 papers). Christopher P. Locher collaborates with scholars based in United States, Germany and Italy. Christopher P. Locher's co-authors include Jay A. Levy, Emanuele Perola, Tiansheng Wang, Robert G. Whalen, Michael H. Cynamon, Carolyn Shoen, Wonsik Lee, Lindsay D. Eltis, Yan‐Cheng Liu and David G. Russell and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Virology.

In The Last Decade

Christopher P. Locher

33 papers receiving 967 citations

Peers

Countries citing papers authored by Christopher P. Locher

Since Specialization

Citations

This map shows the geographic impact of Christopher P. Locher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Locher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Locher more than expected).

Fields of papers citing papers by Christopher P. Locher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Locher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Locher. The network helps show where Christopher P. Locher may publish in the future.

Co-authorship network of co-authors of Christopher P. Locher

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Locher. A scholar is included among the top collaborators of Christopher P. Locher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Locher. Christopher P. Locher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens 2023 ·Nature Communications ·Kevin B. Weyant, (unknown), Sukumar Pal, Julie Liao, (unknown), Thapakorn Jaroentomeechai, Tyler D. Moeller, (unknown), Sean F. Gilmore, (unknown), Daniel C. Pan, David Putnam, Christopher P. Locher, Luis M. de la Maza, Matthew A. Coleman, Matthew P. DeLisa	54
2	2-N-Arylthiazole inhibitors of Mycobacterium tuberculosis 2017 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. Clark, Tiansheng Wang, Emanuele Perola, David D. Deininger, Harmon Zuccola, Steven M. Jones, Hong Gao, Brian C. VanderVen, David G. Russell, Carolyn Shoen, Michael H. Cynamon, John A. Thomson, Christopher P. Locher	9
3	Novel Inhibitors of Cholesterol Degradation in Mycobacterium tuberculosis Reveal How the Bacterium’s Metabolism Is Constrained by the Intracellular Environment 2015 ·PLoS Pathogens ·Brian C. VanderVen, (unknown), Wonsik Lee, Yan‐Cheng Liu, Robert B. Abramovitch, (unknown), Adam M. Crowe, Lindsay D. Eltis, Emanuele Perola, David D. Deininger, Tiansheng Wang, Christopher P. Locher, David G. Russell	203
4	Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine 2009 ·Vaccine ·Lesley C. Dupuy, Christopher P. Locher, Madan Paidhungat, Michelle J. Richards, Cathleen M. Lind, Russell R. Bakken, Michael D. Parker, Robert G. Whalen, Connie S. Schmaljohn	32
5	DNA Shuffling and Screening Strategies for Improving Vaccine Efficacy 2005 ·DNA and Cell Biology ·Christopher P. Locher, Madan Paidhungat, Robert G. Whalen, Juha Punnonen	22
6	Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation 2005 ·Journal of General Virology ·Christopher P. Locher, (unknown), Rachel Kassel, Noah Dowell, Sue H. Fujimura, Jay A. Levy	22
7	Evaluation of Genetic Immunization Adjuvants to Improve the Effectiveness of a Human Immunodeficiency Virus Type 2 (HIV-2) Envelope DNA Vaccine 2004 ·DNA and Cell Biology ·Christopher P. Locher, (unknown), Brittany M. Ashlock, Jay A. Levy	15
8	Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies 2004 ·Expert Opinion on Biological Therapy ·Christopher P. Locher, Volker Heinrichs, Doris Apt, Robert G. Whalen	7
9	Expression Patterns of Phenotypic Markers on Lymphocytes from Human Immunodeficiency Virus Type 2-Infected Baboons 2003 ·AIDS Research and Human Retroviruses ·Christopher P. Locher, Sue H. Fujimura, Krishna K. Murthy, Kathleen M. Brasky, M. Michelle Leland, Jay A. Levy	2
10	Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection 2003 ·Vaccine ·Christopher P. Locher, (unknown), Brittany M. Ashlock, Patricia Polacino, (unknown), Stephen Shiboski, Ann Marie Schmidt, Michael B. Agy, David Anderson, Silvija I. Staprans, Jan zur Megede, Jay A. Levy	19
11	Enhancement of Antibody Responses to an HIV-2 DNA Envelope Vaccine Using an Expression Vector Containing a Constitutive Transport Element 2002 ·DNA and Cell Biology ·Christopher P. Locher, (unknown), Brittany M. Ashlock, Jay A. Levy	6
12	The nuclear factor kappa B and Spl binding sites do not appear to be involved in virus suppression by CD8 T lymphocytes 2001 ·AIDS ·Christopher P. Locher, (unknown), Jay A. Levy	3
13	Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development 2001 ·Immunological Reviews ·Christopher P. Locher, (unknown), Brian Herndier, Klara Tenner‐Racz, Paul Rácz, Jay A. Levy	35
14	Suppression of Viral Replication in a Long-Term Nonprogressing Rhesus Macaque Experimentally Infected with Pathogenic Simian Immunodeficiency Virus (SIV) 1998 ·Clinical Immunology and Immunopathology ·(unknown), Christiane Stahl‐Hennig, Thomas Nißlein, Christopher P. Locher, Dietmar Fuchs, Walter Bodemer, Gerhard Hunsmann, Ulf Dittmer	4
15	Short Communication : Transient Virus Infection and Pathogenesis of a New HIV Type 2 Isolate, UC12, in Baboons 1998 ·AIDS Research and Human Retroviruses ·Christopher P. Locher, David J. Blackbourn, Brian Herndier, Gustavo Reyes‐Terán, Susan W. Barnett, KRISHNA K. MURTHY, Jay A. Levy	15
16	CD8+ cells from HIV-2-infected baboons control HIV replication 1997 ·AIDS ·David J. Blackbourn, Christopher P. Locher, Bineetha Ramachandran, Susan W. Barnett, Krishna K. Murthy, (unknown), Kathleen M. Brasky, Jay A. Levy	29
17	Superinfection with Human Immunodeficiency Virus Type 2 Can Reactivate Virus Production in Baboons but Is Contained by a CD8 T Cell Antiviral Response 1997 ·The Journal of Infectious Diseases ·Christopher P. Locher, David J. Blackbourn, Susan W. Barnett, Krishna K. Murthy, (unknown), (unknown), Giampaolo Greco, Gustavo Reyes‐Terán, Kathleen M. Brasky, (unknown), Jay A. Levy	17
18	Plasmodium falciparum:gp195 Tripeptide Repeat-Specific Monoclonal Antibody Inhibits Parasite Growthin Vitro 1996 ·Experimental Parasitology ·Christopher P. Locher, (unknown), Sandra P. Chang, Jana S. McBride, (unknown)	28
19	Antiviral activity of Hawaiian medicinal plants against human immunodeficiency Virus Type-1 (HIV-1) 1996 ·Phytomedicine ·Christopher P. Locher, Myriam Witvrouw, (unknown), (unknown), Howard F. Mower, Harry Davis, A. Lasure, Rudi Pauwels, Erik De Clercq, Arnold Vlietinck	102
20	Three matrix metalloproteinases form a non-covalent association with the rhoptry-associated protein-1 of Plasmodium falciparum 1992 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Christopher P. Locher, F Vandekerckhove, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact